Abstract:
An volume of a patient can be mapped with a system operable to identify a plurality of locations and save a plurality of locations of a mapping instrument. The mapping instrument can include one or more electrodes that can sense a voltage that can be correlated to a three dimensional location of the electrode at the time of the sensing or measurement. Therefore, a map of a volume can be determined based upon the sensing of the plurality of points without the use of other imaging devices. An implantable medical device can then be navigated relative to the mapping data.
Abstract:
An ECG system is used in ECG signal measurement of intra-cardiac ECG using a catheter. The system includes a lead signal switch for disconnecting an amplifier input terminal from a reference point and reconnecting the input terminal to a patient limb electrode. An ECG signal processor amplifies the difference of a chest lead signal electronically connected to a catheter, and a patient limb signal provided by the reconnecting of the input terminal.
Abstract:
A multi-function health monitor is capable of performing a resting 12-lead ECG test, an ECG stress test, a 24-hour holter monitor evaluation and or a 30-day MCT monitoring. Using only 3 electrodes, the multifunction health monitor derives 6 channels (Limb leads & Augmented leads) of data with the noise cancellation (ground) effect of a virtual dynamic RL electrode. An electrode resistivity measurement system quantifies and may compensate for increasing resistance the electrodes and the patient that results from the length of time the electrodes are installed on a patient. The multi-function health monitor can provide data analysis through the gate array as the data is acquired. Data may also be stored for remote analysis as well as for transmission to remote stations upon occurrence of one or more threshold events. Parameters for threshold events may be adjusted remotely to obviate the need for a patient to travel for system adjustment.
Abstract:
The implantable cardiac treatment system of the present invention is capable of choosing the most appropriate electrode vector to sense within a particular patient. In certain embodiments, the implantable cardiac treatment system determines the most appropriate electrode vector for continuous sensing based on which electrode vector results in the greatest signal amplitude, or some other useful metric such as signal-to-noise ratio (SNR). The electrode vector possessing the highest quality as measured using the metric is then set as the default electrode vector for sensing. Additionally, in certain embodiments of the present invention, a next alternative electrode vector is selected based on being generally orthogonal to the default electrode vector. In yet other embodiments of the present invention, the next alternative electrode vector is selected based on possessing the next highest quality metric after the default electrode vector. In some embodiments, if analysis of the default vector is ambiguous, the next alternative electrode vector is analyzed to reduce ambiguity.
Abstract:
Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
Abstract:
An ECG system is used in ECG signal measurement of intra-cardiac ECG using a catheter. The system includes a lead signal switch for disconnecting an amplifier input terminal from a reference point and reconnecting the input terminal to a patient limb electrode. An ECG signal processor amplifies the difference of a chest lead signal electronically connected to a catheter, and a patient limb signal provided by the reconnecting of the input terminal.
Abstract:
An volume of a patient can be mapped with a system operable to identify a plurality of locations and save a plurality of locations of a mapping instrument. The mapping instrument can include one or more electrodes that can sense a voltage that can be correlated to a three dimensional location of the electrode at the time of the sensing or measurement. Therefore, a map of a volume can be determined based upon the sensing of the plurality of points without the use of other imaging devices. An implantable medical device can then be navigated relative to the mapping data.
Abstract:
An illustrative embodiment includes an implantable cardiac stimulus device comprising input circuitry configured to reduce the time required to return to small signal operation after a disturbance of small signal operation. In another illustrative embodiment, the present invention includes methods for operating an implantable cardiac stimulus device to reduce the time required to return to small signal operation after a disturbance of small signal operation. In yet additional embodiments, the initiation of small signal operation after a change in sensing vector and/or after delivery of a stimulus to the patient is improved by the inclusion of input circuitry and/or the use of methods adapted to reduce the time needed to reach small signal operation.
Abstract:
An apparatus and method for selectively interacting with electrically excitable tissue of a patient are provided. The apparatus includes an implantable pulse generator having a number of output sources that transmit pulse signals. An extension unit couples the implantable pulse generator to an implantable electrode array. The implantable electrode array has a number of electrodes, wherein the number of electrodes is greater than the number of output sources. The extension unit is configured to electrically connect the output sources to a portion of the electrodes.
Abstract:
A biopotential measurement system incorporates a revolutionary approach to the acquisition of signals such as Electroencephalograms (EEG), Electrocardiograms (ECG), and Electromyograms (EMG) by incorporating active, digital electrodes that amplify and digitally convert biopotential signals at the source, thereby eliminating noise and signal degradation issues. This is to date the most integrated and advanced electrode designed for any biopotential measurement eliminating the poor Signal-to-Noise (SNR) problems seen in biopotential recordings.